Effect of oral gavage dosing regimens in female Tg rasH2 transgenic mice

Daniel Morton1, Rani S Sellers, Sylvia M Furst

  • 1Pfizer Drug Safety Evaluation, Skokie, Illinois, USA. dan.g.morton@pfizer.com

Toxicologic Pathology
|June 19, 2004
PubMed

Related Concept Videos